The 9 most recent market catalysts affecting $MDLZ, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 20, 2026
Corporate Catalyst
Bearish
Impact 65
Reported Earlier, FDA Says Medline Issued Correction For Convenience Kits Containing B. Braun Bupivacaine Hydrochloride Components, Identified As Most Serious Recall Type; B. Braun Reported 35 Serious Injuries, No Deaths
The FDA has issued a Class I recall for Medline's convenience kits, which include B. Braun Bupivacaine Hydrochloride components. This is the most serious type of recall, indicating…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Mondelez International, Raises Price Target to $70
Barclays analyst Andrew Lazar maintained an 'Overweight' rating on Mondelez International (MDLZ) and raised the price target from $68 to $70. This action signals continued confiden…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
BNP Paribas Maintains Outperform on Mondelez International, Raises Price Target to $70
BNP Paribas analyst Max Gumport maintained an 'Outperform' rating on Mondelez International (MDLZ) and raised the price target from $68 to $70. This action signals continued confid…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
JP Morgan Maintains Overweight on Mondelez International, Raises Price Target to $72
JP Morgan's analyst Thomas Palmer has updated their outlook on Mondelez International, raising the price target by $2 to $72 while maintaining an 'Overweight' rating. This action s…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on Mondelez International, Raises Price Target to $70
TD Cowen analyst Robert Moskow maintained a 'Buy' rating on Mondelez International (MDLZ) and raised the price target from $67 to $70. This action reflects a continued positive sen…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
Mondelez International shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance with its midpoint above estimates.
This headline is a major positive catalyst for Mondelez International (MDLZ). The better-than-expected Q2 results indicate strong current performance, while the raised FY26 adjuste…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Mondelez International shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
Mondelez's better-than-expected Q2 results and increased FY26 guidance are a significant positive catalyst, demonstrating strong demand for its products and effective cost manageme…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 75
Mondelez International Raises FY2026 Adj EPS Guidance from $2.92-$3.06 to $2.97-$3.12 vs $3.04 Est
Mondelez International (MDLZ) has raised its adjusted EPS guidance for FY2026 from a range of $2.92-$3.06 to $2.97-$3.12, now exceeding the prior analyst estimate of $3.04. This up…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Mondelez International Q2 Adj. EPS $0.73 Beats $0.68 Estimate, Sales $9.355B Beat $9.197B Estimate
Mondelez International announced Q2 adjusted EPS of $0.73, beating the $0.68 estimate, and sales of $9.355 billion, exceeding the $9.197 billion estimate. This strong financial per…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.